Skip to main content
. 2017 Jul 1;21(7):390–403. doi: 10.1089/omi.2017.0045

FIG. 2.

FIG. 2.

Representative MS/MS spectra depicting the overexpression of (A) TNFAIP2 (eightfold), (B) CEBPB (threefold), (C) PLAUR (threefold) and (D) SDCBP (fourfold). TNFAIP2, tumor necrosis factor alpha-induced protein 2; CEBPB, CCAAT/enhancer binding protein; PLAUR, plasminogen activator, urokinase receptor; SDCBP, syndecan binding protein.